⌕
Alvotech · ALVO · Nasdaq
Tenet 41 · Weak
Compare
$4.37−0.79%At closeTenet 41 · Weak
$4.37−0.04 (−0.79%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Alvotech (ALVO) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

Business engineGrowing fast: revenue compounds ~69.7%/yr (FY21→FY25), net margin 3.6%.
The four lines that matter · FY21–FY25
Revenue ($M)▲34.2%
778.5
FY21→FY25CAGR +69.7%/yr
Net income ($M)—
27.9
one-off year: see footnoteCAGR —
Free cash flow ($M)—
—
no FY25 valueCAGR —
Diluted EPS—
—
no FY25 valueCAGR —
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)778.5Revenue−384.7COGS393.8Gross profit−184.2R&D−90.9SG&A118.6Op income−90.7Tax & other27.9Net income

4¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
604530150%sector median net margin ~3%FY21FY25

Over this window: gross -24.9% → 50.6%. Net margin 3.6% is above the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
On the latest annual statement the reported earnings per share does not reconcile with net income to common shareholders divided by the reported share count (a factor of 1.259), so the two figures are on different bases. Both are shown as filed.
USD millions except per-share & ratios
Line itemFY25 †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
778.5778.5580.393.098.193.9▲34.2%+69.7%
Cost of revenue
384.7384.7488.5428.0252.5117.4▼21.2%+34.6%
Gross profit
393.8393.891.8−335.0−154.4−23.4▲328.9%—
Research & development
184.2184.2171.3210.8180.6191.0▲7.5%−0.9%
Selling, general & admin
90.990.965.776.6186.784.1▲38.4%+2.0%
Total operating expenses
275.1275.1237.0308.9367.4275.1▲16.1%−0.0%
Operating incomefeeds ROC rank
118.6118.6−145.2−643.9−521.7−298.6——
Other income, net
17.717.7−72.3−7.2−29.9149.4——
Pretax income
136.3136.3−217.6−651.0−551.6−149.2——
Income tax
108.4108.414.3−99.3−38.1−47.7▲658.2%—
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
27.927.9−231.9−551.7−513.6−101.5——
Per share
Diluted EPSbuyback-sensitive
————−2.60−0.92——
Diluted shares (mn)
312.02312.02301.81266.82248.65—▲3.4%+7.9%
Margins
Gross margin29th pct in Healthcare
50.6%50.6%15.8%−360.1%−157.3%−24.9%▲34.8pp+75.5pp
Operating margin
15.2%15.2%−25.0%−692.2%−531.7%−317.9%▲40.3pp+333.1pp
Net margin51st pct in Healthcare
3.6%3.6%−40.0%−593.1%−523.4%−108.1%▲43.5pp+111.6pp
† FY25 = fiscal 2025, through 2025-12-31; the trailing year is not available.FY21 effective tax rate was 32% vs a 15% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was 7% vs a 15% norm for this window, likely a one-time item; see the filing.
FY20 – FY20 · 1 more year
Unlock the full history →
1 more year of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-03-30 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Alvotech's revenue last fiscal year?

Alvotech reported revenue of $778.5M in fiscal 2025, up 34.2% from fiscal 2024.

What was Alvotech's net income?

Alvotech reported net income of $27.9M in fiscal 2025, a net margin of 3.6%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.